Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 32 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 9 | 350−0.3%/yr | −0.3%/yr | 5.41.7× | 8% | 320 in 2030−1.3%/yr |
| Lumbar fusion | 8 | 338+2.1%/yr | +2.1%/yr | 5.21.6× | 3% | 370 in 2030+1.6%/yr |
| Cervical fusion & disc arthroplasty | 2 | 158−2.2%/yr | −2.2%/yr | 2.51.4× | 10% | 160 in 2030−0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 34 | 5,774−6.9%/yr | −6.9%/yr | 88.90.7× | 51% | 6,110 in 2030+1%/yr |
| Skin substitutes & wound grafts | 4 | 1,007+12%/yr | +12%/yr | 11.61.1× | 83% | 2,200 in 2030+14%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 9 | 229−7.4%/yr | −7.4%/yr | 3.50.3× | 96% | 240 in 2030+0.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 10 | 1,226+9.5%/yr | +9.5%/yr | 18.93.0× | 83% | 1,830 in 2030+6.9%/yr |
| Dialysis access | 3 | 402−12%/yr | −12%/yr | 6.61.2× | 82% | 350 in 2030−2.1%/yr |
| Thrombectomy, IVC filters & venous stents | 1 | 238−4.9%/yr | −4.9%/yr | 3.82.2× | 10% | 210 in 2030−1.8%/yr |
| Superficial venous ablation | 4 | 217−11%/yr | −11%/yr | 3.30.5× | 100% | 270 in 2030+3.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 4 | 587−0.4%/yr | −0.4%/yr | 9.81.6× | 12% | 630 in 2030+1.3%/yr |
| Cholecystectomy & appendectomy | 4 | 315−2.4%/yr | −2.4%/yr | 5.11.1× | 2% | 340 in 2030+1.3%/yr |
| Colorectal resection | 1 | 196−6.3%/yr | −6.3%/yr | 3.21.9× | 0% | 170 in 2030−2.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 6 | 425−0.5%/yr | −0.5%/yr | 6.71.4× | 58% | 390 in 2030−1.5%/yr |
| Kidney stone management | 9 | 387+3.4%/yr | +3.4%/yr | 6.21.2× | 32% | 420 in 2030+1.6%/yr |
| Hysterectomy, hysteroscopy & ablation | 4 | 307+6.1%/yr | +6.1%/yr | 5.22.0× | 31% | 460 in 2030+6.8%/yr |
| Incontinence, prolapse & sacral neuromodulation | 4 | 288+6.1%/yr | +6.1%/yr | 4.61.7× | 13% | 350 in 2030+3.4%/yr |
| Prostatectomy & nephrectomy | 8 | 277+5.5%/yr | +5.5%/yr | 4.73.8× | 0% | 380 in 2030+5.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 3 | 234−13%/yr | −13%/yr | 3.80.7× | 98% | 250 in 2030+0.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 28 | 1,896+2.5%/yr | +2.5%/yr | 31.64.6× | 69% | 2,250 in 2030+2.9%/yr |
| Tumor & fibroid embolization | 3 | 100−4.1%/yr | −4.1%/yr | 1.62.8× | 87% | 160 in 2030+7.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 17 | 1,276+12%/yr | +12%/yr | 20.10.7× | 100% | 2,370 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| EP ablation | 8 | 503+10%/yr | +10%/yr | 7.11.9× | 0% | 1,040 in 2030+13%/yr |
| Pacemaker, ICD & CRT implantation | 10 | 494−2.1%/yr | −2.1%/yr | 8.11.4× | 0% | 510 in 2030+0.4%/yr |
| LAA occlusion & loop recorders | 8 | 352+11%/yr | +11%/yr | 5.11.4× | 43% | 630 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 8 | 452−5.7%/yr | −5.7%/yr | 6.31.0× | 0% | 550 in 2030+3.3%/yr |
| Structural heart (TAVR, TEER) | 8 | 271−1.1%/yr | −1.1%/yr | 3.82.5× | 0% | 310 in 2030+2.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 29 | 3,191+3%/yr | +3%/yr | 50.10.9× | 95% | 4,020 in 2030+3.9%/yr |
| Vitreoretinal surgery | 3 | 175−2.1%/yr | −2.1%/yr | 2.81.1× | 51% | 260 in 2030+6.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 54 | 6,341−4.7%/yr | −4.7%/yr | 103.70.9× | 56% | 6,640 in 2030+0.8%/yr |
| Bronchoscopy & lung nodule | 7 | 762+4.4%/yr | +4.4%/yr | 12.23.7× | 0% | 1,250 in 2030+8.6%/yr |
| ERCP & endoscopic ultrasound | 6 | 706−0.3%/yr | −0.3%/yr | 11.43.5× | 0% | 760 in 2030+1.2%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.